MedPath

四川省旭晖制药有限公司

Ownership
-
Established
2012-09-21
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

NMPA:12

Drug Approvals

Levamlodipine Besilate Tablets

Product Name
苯磺酸左氨氯地平片
Approval Number
国药准字H20249815
Approval Date
Dec 25, 2024
NMPA

Amlexanox Oral Paste

Product Name
西抒迈
Approval Number
国药准字H20080260
Approval Date
Nov 21, 2022
NMPA

Cilostazol Tablets

Product Name
西洛他唑片
Approval Number
国药准字H20074099
Approval Date
Mar 21, 2022
NMPA

Cilostazol Tablets

Product Name
西洛他唑片
Approval Number
国药准字H20074100
Approval Date
Mar 21, 2022
NMPA

Zolmitriptan Tablets

Product Name
佐米曲普坦片
Approval Number
国药准字H20070130
Approval Date
Feb 24, 2022
NMPA

Fexofenadine Hydrochloride

Product Name
盐酸非索非那定
Approval Number
国药准字H20070133
Approval Date
Feb 24, 2022
NMPA

Zolmitriptan Tablets

Product Name
佐米曲普坦片
Approval Number
国药准字H20070131
Approval Date
Feb 24, 2022
NMPA

Fexofenadine Hydrochloride Tablets

Product Name
毕馨
Approval Number
国药准字H20070124
Approval Date
Feb 24, 2022
NMPA

Cilostazol

Product Name
西洛他唑
Approval Number
国药准字H20066020
Approval Date
Mar 9, 2021
NMPA

Metronidazole Tablets

Product Name
甲硝唑片
Approval Number
国药准字H61020729
Approval Date
Feb 3, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.